These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 22231906)

  • 21. Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients.
    Saucier D; Wajnberg G; Roy J; Beauregard AP; Chacko S; Crapoulet N; Fournier S; Ghosh A; Lewis SM; Marrero A; O'Connell C; Ouellette RJ; Morin PJ
    Brain Res; 2019 Apr; 1708():100-108. PubMed ID: 30552897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integration of MicroRNA databases to study MicroRNAs associated with multiple sclerosis.
    Angerstein C; Hecker M; Paap BK; Koczan D; Thamilarasan M; Thiesen HJ; Zettl UK
    Mol Neurobiol; 2012 Jun; 45(3):520-35. PubMed ID: 22549745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis.
    Keller A; Leidinger P; Meese E; Haas J; Backes C; Rasche L; Behrens JR; Pfuhl C; Wakonig K; Gieß RM; Jarius S; Meder B; Bellmann-Strobl J; Paul F; Pache FC; Ruprecht K
    J Neuroinflammation; 2015 Oct; 12():196. PubMed ID: 26521232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression.
    Allantaz F; Cheng DT; Bergauer T; Ravindran P; Rossier MF; Ebeling M; Badi L; Reis B; Bitter H; D'Asaro M; Chiappe A; Sridhar S; Pacheco GD; Burczynski ME; Hochstrasser D; Vonderscher J; Matthes T
    PLoS One; 2012; 7(1):e29979. PubMed ID: 22276136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The identification of up-regulated ebv-miR-BHRF1-2-5p targeting MALT1 and ebv-miR-BHRF1-3 in the circulation of patients with multiple sclerosis.
    Wang YF; He DD; Liang HW; Yang D; Yue H; Zhang XM; Wang R; Li B; Yang HX; Liu Y; Chen Y; Duan YX; Zhang CY; Chen X; Fu J
    Clin Exp Immunol; 2017 Jul; 189(1):120-126. PubMed ID: 28253538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigating the Role of MicroRNA and Transcription Factor Co-regulatory Networks in Multiple Sclerosis Pathogenesis.
    Nuzziello N; Vilardo L; Pelucchi P; Consiglio A; Liuni S; Trojano M; Liguori M
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis.
    Groen K; Maltby VE; Lea RA; Sanders KA; Fink JL; Scott RJ; Tajouri L; Lechner-Scott J
    BMC Med Genomics; 2018 May; 11(1):48. PubMed ID: 29783973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating miR-155-5p as a Novel Biomarker of Lumbar Degenerative Disc Disease.
    Divi SN; Markova DZ; Fang T; Guzek R; Kurd MF; Rihn JA; Hilibrand AS; Anderson DG; Vaccaro AR; Schroeder GD; Kepler CK
    Spine (Phila Pa 1976); 2020 May; 45(9):E499-E507. PubMed ID: 31770330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of hub lncRNA ceRNAs in multiple sclerosis based on ceRNA mechanisms.
    Ding Y; Li T; Yan X; Cui M; Wang C; Wang S; Zhang F; Zhang R
    Mol Genet Genomics; 2021 Mar; 296(2):423-435. PubMed ID: 33507382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Messenger RNA and MicroRNA transcriptomic signatures of cardiometabolic risk factors.
    McManus DD; Rong J; Huan T; Lacey S; Tanriverdi K; Munson PJ; Larson MG; Joehanes R; Murthy V; Shah R; Freedman JE; Levy D
    BMC Genomics; 2017 Feb; 18(1):139. PubMed ID: 28178938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma.
    Wang Y; Gao Y; Shi W; Zhai D; Rao Q; Jia X; Liu J; Jiao X; Du Z
    Cancer Biomark; 2015; 15(2):171-80. PubMed ID: 25519019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exosome-associated miRNA profile as a prognostic tool for therapy response monitoring in multiple sclerosis patients.
    Manna I; Iaccino E; Dattilo V; Barone S; Vecchio E; Mimmi S; Filippelli E; Demonte G; Polidoro S; Granata A; Scannapieco S; Quinto I; Valentino P; Quattrone A
    FASEB J; 2018 Aug; 32(8):4241-4246. PubMed ID: 29505299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression levels of IL-17/IL-23 cytokine-targeting microRNAs 20, 21, 26, 155, and Let-7 in patients with relapsing-remitting multiple sclerosis.
    Balkan E; Bilge N
    Neurol Res; 2021 Sep; 43(9):778-783. PubMed ID: 34130607
    [No Abstract]   [Full Text] [Related]  

  • 34. Expression Profile of Selected MicroRNAs in the Peripheral Blood of Multiple Sclerosis Patients: a Multivariate Statistical Analysis with ROC Curve to Find New Biomarkers for Fingolimod.
    Eftekharian MM; Komaki A; Mazdeh M; Arsang-Jang S; Taheri M; Ghafouri-Fard S
    J Mol Neurosci; 2019 May; 68(1):153-161. PubMed ID: 30895441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an integrated approach to uncover novel pathogenic mechanisms of the disease.
    Liguori M; Nuzziello N; Licciulli F; Consiglio A; Simone M; Viterbo RG; Creanza TM; Ancona N; Tortorella C; Margari L; Grillo G; Giordano P; Liuni S; Trojano M
    Hum Mol Genet; 2018 Jan; 27(1):66-79. PubMed ID: 29087462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma microRNAs characterising patients with immune thrombocytopenic purpura.
    Zuo B; Zhai J; You L; Zhao Y; Yang J; Weng Z; Dai L; Wu Q; Ruan C; He Y
    Thromb Haemost; 2017 Jun; 117(7):1420-1431. PubMed ID: 28424819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture.
    Supriya M; Christopher R; Indira Devi B; Bhat DI; Shukla D
    Mol Diagn Ther; 2020 Jun; 24(3):351-364. PubMed ID: 32323261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosomal microRNA signatures in multiple sclerosis reflect disease status.
    Ebrahimkhani S; Vafaee F; Young PE; Hur SSJ; Hawke S; Devenney E; Beadnall H; Barnett MH; Suter CM; Buckland ME
    Sci Rep; 2017 Oct; 7(1):14293. PubMed ID: 29084979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential circulating miRNA signature for early detection of NSCLC.
    Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
    Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double-blind, placebo-controlled trial.
    Dolati S; Aghebati-Maleki L; Ahmadi M; Marofi F; Babaloo Z; Ayramloo H; Jafarisavari Z; Oskouei H; Afkham A; Younesi V; Nouri M; Yousefi M
    J Cell Physiol; 2018 Jul; 233(7):5222-5230. PubMed ID: 29194612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.